Discovery of Potent and Selective Inhibitors of Human Reticulocyte 15-Lipoxygenase-1
- 24 September 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (20), 7392-7404
- https://doi.org/10.1021/jm1008852
Abstract
There are a variety of lipoxygenases in the human body (hLO), each having a distinct role in cellular biology. Human reticulocyte 15-lipoxygenase-1 (15-hLO-1), which catalyzes the dioxygenation of 1,4-cis,cis-pentadiene-containing polyunsaturated fatty acids, is implicated in a number of diseases including cancer, atherosclerosis, and neurodegenerative conditions. Despite the potential therapeutic relevance of this target, few inhibitors have been reported that are both potent and selective. To this end, we have employed a quantitative high-throughput (qHTS) screen against ∼74000 small molecules in search of reticulocyte 15-hLO-1 selective inhibitors. This screen led to the discovery of a novel chemotype for 15-hLO-1 inhibition, which displays nM potency and is >7500-fold selective against the related isozymes, 5-hLO, platelet 12-hLO, epithelial 15-hLO-2, ovine cyclooxygenase-1, and human cyclooxygenase-2. In addition, kinetic experiments were performed which indicate that this class of inhibitor is tight binding, reversible, and appears not to reduce the active-site ferric ion.Keywords
This publication has 62 references indexed in Scilit:
- Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescenceOncogene, 2010
- Using Enzyme Assays to Evaluate the Structure and Bioactivity of Sponge-Derived MeroterpenesJournal of Natural Products, 2009
- Kinetic and Structural Investigations of the Allosteric Site in Human Epithelial 15-Lipoxygenase-2Biochemistry, 2009
- A Robotic Platform for Quantitative High-Throughput ScreeningASSAY and Drug Development Technologies, 2008
- Substrate Specificity Changes for Human Reticulocyte and Epithelial 15-Lipoxygenases Reveal Allosteric Product RegulationBiochemistry, 2008
- Comprehensive Mechanistic Analysis of Hits from High-Throughput and Docking Screens against β-LactamaseJournal of Medicinal Chemistry, 2008
- Structure–activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2Bioorganic & Medicinal Chemistry, 2007
- Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse librariesBioorganic & Medicinal Chemistry, 2007
- Novel lipoxygenase inhibitors as neuroprotective reagentsJournal of Neuroscience Research, 2007
- Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical librariesProceedings of the National Academy of Sciences, 2006